{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Synthetic replication via OTC swaps, counterparty risk, structured derivatives exposure",
    "classification": "complex",
    "supporting_data": "The Amundi FTSE 100 UCITS ETF Acc uses synthetic replication by entering into an OTC swap contract to replicate the FTSE 100 Total Return Index performance. This involves derivative instruments integral to the investment objective, introducing counterparty risk and collateral risk, which are difficult for retail investors to understand. The ETF does not use physical replication but relies on swaps, which under MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, generally classifies such ETFs as complex. Although it is a UCITS ETF, the use of synthetic replication and derivatives as a core strategy overrides the baseline non-complex presumption. There is no indication of leverage beyond UCITS limits, but the embedded swap exposure and derivative use for replication make the product complex. The ETF's structure and risks are not straightforward for retail investors with basic knowledge, requiring an appropriateness assessment under MiFID II. This aligns with ESMA guidance that synthetic ETFs and structured UCITS should be considered complex and subject to appropriateness tests. Therefore, despite being a UCITS ETF, the synthetic replication and derivative use classify it as complex under MiFID II rules."
}